期刊文献+

亚甲兰光化学法对血浆乙肝病毒的灭活 被引量:1

Methylene blue photochemical technique inactivation activity on hepatitis B virus in human plasma
原文传递
导出
摘要 目的:研究灭活病毒对乙肝病毒和血浆成分的影响。方法:在已知HBV-DNA阳性血浆中加入MB,调整MB终浓度分别为1.0μmol/l、5.0μmol/l、10.0μmol/l,光照度为40000LUX,照射时间分别为0min、20min、40min、60min,在各点分别取样抽提基因组DNA用于荧光定量分析,测定HBV-DNA的浓度,推断在不同时间和浓度下的灭活效果。在灭活效果最好的点取样检测血浆正常成分有无显著变化,其中包括生化指标,酶学指标,凝血因子FⅧ:C活性,SDS聚丙烯酰胺凝胶电泳观察蛋白亚基的变化,蛋白免疫印迹观察血浆的抗体蛋白活性变化。结果:当MB为10.0μmol/L,光照60min时,灭活乙肝病毒的效果最好,对于高拷贝数的病毒浓度,在本实验的条件下,尚无法完全灭活病毒,但可以使HBV-DNA浓度明显下降;从病毒灭活的表格看,灭活效果与时间和MB浓度呈正相关,作用60min时血浆中主要成分的生化指标无显著变化及凝血因子FⅧ:C活性无明显改变,部分血浆酶活性有明显下降(P<0.05)。血浆蛋白的亚基数目和迁移速度未见明显变化,血浆的抗体蛋白也具有正常的生物学活性。结论:MB10μmol/L辅助荧光光照60min可使血浆中乙肝病毒量明显降低,血浆的大多数成分能保持较高活性。 Objective:To investigate the effect of the methylene blue on Hepatitis B virus and compositions of plasma. Methods: 1.0μmol/L, 5.0μ mol/L, 10.0μ mol/L Methylene blue (MB) were added to Hepatitis B Virus (HBV) DNA-positive human blood plasma. Each concentration solutions was subjected to irradiation intensity of 40000LUX within 0,20, 40 and 60 minutes. DNA concentration of each concentration solutions, which were subjected to irradiation intensity of 40000LUX within 0 , 20, 40, and 60 minutes, was determined by FQ-PCR assay. The effects of the MB and time in subjecting to light on the HBV DNA-positive human blood plasma were detected. The plasma fraction, the biochemical index, the enzymology index, and the coagulation factor F Ⅷ :C activity were determined. The sub-unit were observed by SDS-PAGE, and plasma antibodies were also detected by western-blot. Results: The experiment showed that the most effective concentration of MB and length of irradiation time was 10.0?mol/L and 60 minutes, respectively. The result showed that methylene blue could not inactivate high copy viruses, but it could decrease the concentration of viruses. The irradiation time and concentration were positively correlated to the inactivation effect. There was no notable change of the plasma principle constitution when irradiated for 60 minutes. There was no influence for blood coagulation factor FⅧ : C activity, but the action of some enzymes decreased (P〈0.05). The subunit and moving speed had no conspicuous change, while the antibodies had normal biological activity. Conclusion: The HBV concentration in human blood plasma decreased when treated by 10?mol/L methylene blue and visible light irradiating for 60 min, and the activities of blood plasma remained normal.
出处 《现代生物医学进展》 CAS 2010年第5期916-919,共4页 Progress in Modern Biomedicine
关键词 亚甲蓝 病毒灭活 Methylene blue Inactivate virus
  • 相关文献

参考文献14

  • 1McCullough J. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections[J]. Am J Clin Pathol.2007, 128(6): 945-55.
  • 2Girones N, Bueno JL, Carrion J,et al. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma [M]. Vox Sang,2006, 91 (4): 285-91.
  • 3Osselaer JC, Debry C, Goffaux M, et al. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen [M]. Transfusion,2008, 48 (1):108-17.
  • 4朱彪,吴南屏,Armin Bader,Norbert Brockmeyer.高效抗逆转录病毒治疗的HIV/HBV重叠感染者耐药HBV毒株C区和P区基因序列分析[J].浙江大学学报(医学版),2003,32(6):507-509. 被引量:1
  • 5Rache S, Sarmela T, Meghan BB,et al. Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization[J]. Society of Surgical Oncology, 2003, 10:242-247.
  • 6Johnstone MT, Lam JY, Lacoste L, et al. Methylene blue inhibits the antithrombotic effect of nitroglycerin [J]. J Am Coll Cardiol, 1993, 21:255-259.
  • 7Atance R, Pereira A, and Ramirez B.Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate [J]. Transfusion, 2001,41(12): 1548-52.
  • 8Suontaka AM, Blomback M, and Chapman J. Changes in functional activities of plasma fibrinogen aider treatment with methylene blue and red light[J]. Transfusion, 2003, 43(5): 568-75.
  • 9Rachel PMD, Steve GRP, and David MMD.Methylene Blue-induced Phototoxicity An Unrecognized Complication [J]. Pediatrics,1996,97 (5):717-721.
  • 10GabrieUi D, Belisle E, Severino D,et al. Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions[J]. Photochem Photobiol. 2004, 79(3):227-32.

二级参考文献11

  • 1[1]WU Nan-ping, LI Dan, BADER A, et al(吴南屏,李丹,Armin Bader,等).Evaluation of seruminter-leukin-18 and interleukin-10 in patients with HIV-1 and hepatitis viruses co-infected subjects [J]. Journal of Zhejiang University:Medical Sciences(浙江大学学报:医学版),2003,32(2):94-96.(in Chinese)
  • 2[2]ZOU Wei,WU Nan-ping,BADER A,et al(邹薇,吴南屏,Armin Bader,等).Drug resistance of HIV-infected patients after the failure of highly active antiretroviral treatment [J]. Journal of Zhejiang University:Medical Sciences(浙江大学学报:医学版),2003,32(2):104-106.(in Chinese)
  • 3[3]ZHAO Nian-feng,SHU Guan-guan,ZHOU Yong(赵年丰,苏关关,周勇).Preliminary observation on the efficiency and safety of Lamivudine used in decompensative hepatic cirrhosis(B)accompanied by hypersplenism [J].Journal of Zhejiang Unviersity:Medical Scinces(浙江大学学报:医学版),2002,31(6):461-463.(in Chinese)
  • 4[4]YAO G B. Management of HBV in China [J]. J Med Virology,2000,61(3):329-397.
  • 5[5]JARDI R,BUTI M,RODRIGUEZ-FRIAS F,et al.rapid detection of Lamivudine-rssistant hepatitis B virus polymerase gene variants [J]. J Virol Methods,1999,83(1-2):181-187.
  • 6[6]ONO S K, KATO N, SHIRATORI Y, et al. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance [J]. J Clin Invest, 2001,107(4):449-455.
  • 7[7]DELANEY W E, EDWARDS R, COLLEDGE D, et al. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus [J]. Antimicrob Agents Chemother, 2001,45(6):1705-1713.
  • 8[8]STUYVER L J, LOCARNINI S A, LOK A, et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region [J]. Hepato-logy, 2001,33(3):751-757.
  • 9[9]YEH C T, CHIEN R N, CHU C M, et al. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants du-ring prolonged lamivudine therapy [J]. Hepatology, 2000,31(6),1318-1326.
  • 10[10]CANE P A, MUTIMER D, RATCLIFFE D, et al .Analysis of hepatitis B virus quasispecies changes du-ring emergence and reversion of lamivudine resistance in liver transplantation [J]. Antivir Ther,1999,4(1):7-14.

同被引文献31

  • 1Mannucci PM,Schimpf K,Abe T,et al.Low risk of viral infection after administration of vapor-heated factor Ⅷ concentrate.International Investigator Group[J].Transfusion,1992,32 (2):134-138.
  • 2Gao F,Prince AM,Pascual D,et al.Enhancement in the safety of immune globulins prepared from high-risk plasma[J].Vox Sang,1993,64(4):204-209.
  • 3Anon.Ways to reduce the risk of transmission of virus infections by plasma and plasma products[J].Vox Sang,1988,54(4):228-245.
  • 4Burnouf T,Goubran HA,Radosevich M,et al.A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system[J].Transfusion,2006,46(12):2100-2108.
  • 5钱开诚.血液成分病毒灭活研究的进展[C]//中国输血协会第3届输血大会论文专辑.成都:中国输血杂志编辑部,2004,36-38.
  • 6Nakagami T,Ohno H,Shigehisa T,et al.Inactivation of human immunodeficiency virus by high hydrostatic pressure[J].Transfusion,1996,36(5):475-476.
  • 7Bradley DW,Hess RA,Tao F,et al.Pressure cycling technology:a novel approach to virus inactivation in plasma[J].Transfusion,2000,40(2):193-200.
  • 8Osselaer JC,Debry C,Goffaux M,et al.Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods:methylene blue and amotosalen[J].Transfusion,2008,48(1):108-117.
  • 9Lin L,Cook DN,Wiesehahn GP,et al.Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light[J].Transfusion,1997,37(4):423-435.
  • 10Jordan CT,Saakadze N,Newman JL,et al.Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model[J].Transfusion,2004,44 (8):1159-1165.

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部